The 18th Annual Non-Dilutive Funding Summit
The 18th Non-Dilutive Funding Summit brought together hundreds of life science industry leaders with directors at ARPA-H, BARDA, SEED, NIA, NHLBI, NIAID, NINDS, and CIRM, so the innovators could learn about non-dilutive funding opportunities for their R&D directly from the funding agencies.
This free summit is hosted by the FreeMind Group. FreeMind helps companies secure non-dilutive funding for life science R&D and wins over $100 million each year for clients. Follow us on LinkedIn or get our newsletter for news about non-dilutive funding opportunities, announcements about conferences with the best partnering, and discounts for those conferences. The 19th Non-Dilutive Funding Summit will be January 10, 2024.
NIH Support for Biomedical Product Development
Small Business Education and Entrepreneurial Development (SEED)
Small Business Education and Entrepreneurial Development (SEED) accelerates the conversion of scientific discoveries into healthcare solutions. SEED identifies and scales approaches that enable researchers at small businesses, in academic, and elsewhere to convert scientific discoveries into impactful healthcare solutions. SEED also coordinates early-stage product development activities across the National Institutes of Health (NIH) and collaborates with universities and research institutions, small businesses, trade associations and societies, angel investors, venture capitalists, and strategic partners. SEED educates and assists NIH-funded innovators as they transition from discovery science to product development. SEED helps academic innovators validate the potential health impacts of their discoveries through a national network of proof-of-concept centers and provides a host of professional advisory services to small business innovators funded by NIH’s $1.2 billion/year SBIR and STTR programs.
Dr. Matthew McMahon
Dr. Matthew McMahon leads the Small Business Education and Entrepreneurial Development Office (SEED) helping to transform cutting-edge technologies into products that improve health and save lives. He has a diverse background in academia, small business, congressional policy, and NIH program management. He previously served as the first director of the National Heart, Lung, and Blood Institute’s Office of Translational Alliances and Coordination, and he created and led the National Eye Institute’s Office of Translational Research. His previous experience also includes service as the principal scientist for the bionic eye company Second Sight Medical Products and as a staff member on both the United States Senate and House of Representatives committees responsible for science, technology, and innovation policy. Dr. McMahon holds a B.S. in Optical Engineering from the University of Rochester and an M.A. and Ph.D. in Experimental Psychology from the University of California, San Diego.
Reserve Your Place Today
Register Now Free of Charge
For the 19th Annual Non-Dilutive Funding Summit (NDFS)
Wednesday, January 10, 2024
To Join Hundreds of Life Science Industry Leaders
In Learning about Non-Dilutive Funding Opportunities for Your R&D.
Speakers, location, and all other details to be announced.
Register now to receive updates.
Follow us on LinkedIn or request our newsletter to receive:
- News about non-dilutive funding opportunities
- Announcements about conferences with the best partnering for life science professionals
- Discounts for those conferences.
